NATURE’S SUNSHINE PRODUCTS, INC. Deferred Tax Assets, Goodwill and Intangible Assets
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) had Deferred Tax Assets, Goodwill and Intangible Assets of $112.00 thousand as of 2024-12-31, per its 10-K filed 2025-03-11.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets · last filed 2025-03-11
- 2024-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $112.00K.
- 2023-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $101.00K.
- 2022-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $115.00K.
- 2021-12-31: Deferred Tax Assets, Goodwill and Intangible Assets $131.00K.
| Period end | Deferred Tax Assets, Goodwill and Intangible Assets |
|---|---|
| 2024-12-31 | $112.00K 10-K · filed 2025-03-11 |
| 2023-12-31 | $101.00K 10-K · filed 2025-03-11 |
| 2022-12-31 | $115.00K 10-K · filed 2024-03-12 |
| 2021-12-31 | $131.00K 10-K · filed 2023-03-16 |
| 2020-12-31 | $149.00K 10-K · filed 2022-03-08 |
| 2019-12-31 | $161.00K 10-K · filed 2021-03-10 |
| 2018-12-31 | $151.00K 10-K · filed 2020-03-11 |
| 2017-12-31 | $142.00K 10-K · filed 2019-03-08 |
| 2016-12-31 | $237.00K 10-K · filed 2018-03-16 |
| 2015-12-31 | $267.00K 10-K · filed 2017-03-14 |
| 2014-12-31 | $442.00K 10-K · filed 2016-03-14 |
| 2013-12-31 | $389.00K 10-K · filed 2015-03-13 |
| 2012-12-31 | $2.31M 10-K · filed 2014-03-17 |
| 2011-12-31 | $8.08M 10-K · filed 2013-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |